Fig. 5From: Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemiaMTT assay for optimal dosages of SF + BP treatment for BMSCs in vitro. BMSCs (1 × 105 cells/ml) were respectively incubated with different concentrations of SF, BP, SF + BP in 96-well plates for 48 h, and the absorbance at 540 nm in every plate was recorded. The viabilities of Cells (a, b and c) were expressed as the percentage of untreated control in the function of different concentrations of SF, BP, SF + BP. We finally selected the SF dosage of 5 μg/ml and the BP dosage of 0.75 μg/ml for next experiment in vitro according to the experimental resultBack to article page